The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1976, 117: 927-934.
Copyright © 1976 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, W. Y.
Right arrow Articles by Sehon, A. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lee, W. Y.
Right arrow Articles by Sehon, A. H.

Suppression of Reaginic Antibody Formation1

IV. Suppression of Reaginic Antibodies to Penicillin in the Mouse

Weng Y. Lee2 and Alec H. Sehon

MRC Group for Allergy Research, Department of Immunology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada, R3E 0W3

Abstract

Reaginic antibodies to the benzylpenicilloyl determinant (BPO) and ovalbumin (OA) were induced readily in B6D2F1 mice by a single i.p. injection of either 1 or 10 µg of BPO4-OA suspended with 1 mg of Al(OH)3 in 0.5 ml of saline. Administration of conjugates consisting of the hapten coupled to the isologous, nonimmunogenic murine {gamma}-globulins (M{gamma}G), i.e., BPO9-M{gamma}G, BPO11-M{gamma}G, or BPO12-M{gamma}G, resulted in complete and specific suppression of the induction of the anti-BPO reaginic antibody response without affecting, however, the level of reaginic antibodies to OA. Further study of the effect of epitope density on the immunologic properties of BPOx-M{gamma}G revealed that a) the lightly haptenated conjugates, BPO1-M{gamma}G and BPO2.9-M{gamma}G, were not immunosuppressive, b) the conjugates, BPO4.3-M{gamma}G and BPO19-M{gamma}G, were partially tolerogenic, and c) the heavily haptenated conjugate, BPO31-M{gamma}G, was nontolerogenic. Moreover, most importantly, the ongoing anti-BPO response in sensitized mice was readily abrogated by either four daily or four weekly injections of BPO9-M{gamma}G. The immunosuppressive effect of BPO12-M{gamma}G conjugates was dose dependent, complete suppression being achieved with 200 µg of the tolerogen. The unresponsiveness to BPO of spleen cells from immunosuppressed donors was also maintained in adoptive cell transfer experiments in spite of the additional administrationof the immunizing antigen under conditions expected to yield a secondary IgE response. Hence, it is suggested that, with special precautions to prevent unleashing an anaphylactic shock, treatment of penicillin-sensitive individuals with polyvalent conjugates of an appropriate number of BPO groups per human {gamma}-globulin molecule would constitute a rational immunotherapeutic procedure for the abrogation of the allergic response to BPO.

Footnotes

1 This investigation was supported by grants from the Medical Research Council of Canada, Ottawa (Ontario).

2 Holder of a scholarship from the Medical Research Council of Canada.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1976 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1976 by The American Association of Immunologists, Inc. All rights reserved.